Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock	Preferred Stock	Additional Paid-in Capital	Subscriptions Receivable	Accumulated Deficit during Development Stage	Noncontrolling Interest	Issued For Cash At Zero Point Zero One Dollars Per Unit	Issued For Cash At Zero Point Zero One Dollars Per Unit Common Stock	Issued For Cash At Ten Dollar Per Unit	Issued For Cash At Ten Dollar Per Unit Common Stock	Issued For Cash At Ten Dollar Per Unit Additional Paid-in Capital	Stock Issuance Cost Charged To Additional Paid In Capital	Stock Issuance Cost Charged To Additional Paid In Capital Additional Paid-in Capital	Issued For Marketable Securities At Ten Dollar Per Unit	Issued For Marketable Securities At Ten Dollar Per Unit Common Stock	Issued For Marketable Securities At Ten Dollar Per Unit Additional Paid-in Capital	Issued For Cash At Fifteen Dollar Per Unit	Issued For Cash At Fifteen Dollar Per Unit Common Stock	Issued For Cash At Fifteen Dollar Per Unit Additional Paid-in Capital	Equity Issued in Business Combination	Equity Issued in Business Combination Common Stock	Equity Issued in Business Combination Additional Paid-in Capital	Issued As Gift For Ten Dollar And Ninety Cents Per Share	Issued As Gift For Ten Dollar And Ninety Cents Per Share Common Stock	Issued As Gift For Ten Dollar And Ninety Cents Per Share Additional Paid-in Capital	Issued As Stock Issuance Cost At Fifteen Dollar Per Unit	Issued As Stock Issuance Cost At Fifteen Dollar Per Unit Common Stock	Issued As Stock Issuance Cost At Fifteen Dollar Per Unit Additional Paid-in Capital	Exercised At Two Dollar Per Share	Exercised At Two Dollar Per Share Common Stock	Exercised At Two Dollar Per Share Additional Paid-in Capital	Exercised At Ten Dollar Per Share	Exercised At Ten Dollar Per Share Common Stock	Exercised At Ten Dollar Per Share Additional Paid-in Capital	Exercised At Fifteen Dollar Per Share	Exercised At Fifteen Dollar Per Share Common Stock	Exercised At Fifteen Dollar Per Share Additional Paid-in Capital	Issued To Purchase Insert Therapeutics Share At Thirty Nine Dollars And Eighty Cents Per Share	Issued To Purchase Insert Therapeutics Share At Thirty Nine Dollars And Eighty Cents Per Share Common Stock	Issued To Purchase Insert Therapeutics Share At Thirty Nine Dollars And Eighty Cents Per Share Additional Paid-in Capital	Issued At Forty Eight Dollars And Eighty Cents Per Share	Issued At Forty Eight Dollars And Eighty Cents Per Share Common Stock	Issued At Forty Eight Dollars And Eighty Cents Per Share Additional Paid-in Capital	Issued At Thirty Eight Dollars And Forty Cents Per Share	Issued At Thirty Eight Dollars And Forty Cents Per Share Common Stock	Issued At Thirty Eight Dollars And Forty Cents Per Share Additional Paid-in Capital	Issued At Thirty Five Dollars Per Share	Issued At Thirty Five Dollars Per Share Common Stock	Issued At Thirty Five Dollars Per Share Additional Paid-in Capital	Issued At Fifty Nine Dollars And Ten Cents Per Share	Issued At Fifty Nine Dollars And Ten Cents Per Share Common Stock	Issued At Fifty Nine Dollars And Ten Cents Per Share Additional Paid-in Capital	Issued To Purchase Calando Pharmaceuticals Inc At Fifty One Dollars And Seventy Cents Per Share	Issued To Purchase Calando Pharmaceuticals Inc At Fifty One Dollars And Seventy Cents Per Share Common Stock	Issued To Purchase Calando Pharmaceuticals Inc At Fifty One Dollars And Seventy Cents Per Share Additional Paid-in Capital	Issued At Fifty Seven Dollars And Eighty Cents Per Share	Issued At Fifty Seven Dollars And Eighty Cents Per Share Common Stock	Issued At Fifty Seven Dollars And Eighty Cents Per Share Additional Paid-in Capital	Issued For Purchase Of Carbon Nanotechnologies Inc At Thirty Seven Dollars And Seventy Cents Per Share	Issued For Purchase Of Carbon Nanotechnologies Inc At Thirty Seven Dollars And Seventy Cents Per Share Common Stock	Issued For Purchase Of Carbon Nanotechnologies Inc At Thirty Seven Dollars And Seventy Cents Per Share Additional Paid-in Capital	Issued At Approximately Eighteen Dollar Per Share Net	Issued At Approximately Eighteen Dollar Per Share Net Common Stock	Issued At Approximately Eighteen Dollar Per Share Net Additional Paid-in Capital	Issued At Twenty Seven Dollars And Twenty Cents Per Share To Rice University	Issued At Twenty Seven Dollars And Twenty Cents Per Share To Rice University Common Stock	Issued At Twenty Seven Dollars And Twenty Cents Per Share To Rice University Additional Paid-in Capital	Issued At Twenty Eight Dollars And Thirty Cents Per Share To Purchase Shares Of Unidym Inc	Issued At Twenty Eight Dollars And Thirty Cents Per Share To Purchase Shares Of Unidym Inc Common Stock	Issued At Twenty Eight Dollars And Thirty Cents Per Share To Purchase Shares Of Unidym Inc Additional Paid-in Capital	Issued At Twenty Nine Dollars And Fifty Cents Per Share To Purchase Masa Energy Llc	Issued At Twenty Nine Dollars And Fifty Cents Per Share To Purchase Masa Energy Llc Common Stock	Issued At Twenty Nine Dollars And Fifty Cents Per Share To Purchase Masa Energy Llc Additional Paid-in Capital	Issued At Twenty One Dollars And Ninety Cents Per Share To Unidym For Acquisition Of Nanoconduction	Issued At Twenty One Dollars And Ninety Cents Per Share To Unidym For Acquisition Of Nanoconduction Common Stock	Issued At Twenty One Dollars And Ninety Cents Per Share To Unidym For Acquisition Of Nanoconduction Additional Paid-in Capital	Issued At Twenty One Dollars And Eighty Cents Per Share	Issued At Twenty One Dollars And Eighty Cents Per Share Common Stock	Issued At Twenty One Dollars And Eighty Cents Per Share Additional Paid-in Capital	Issued At Five Dollars And Fifty Cents Per Share To Unidym Stockholder In Exchange For Unidym S Shares	Issued At Five Dollars And Fifty Cents Per Share To Unidym Stockholder In Exchange For Unidym S Shares Common Stock	Issued At Five Dollars And Fifty Cents Per Share To Unidym Stockholder In Exchange For Unidym S Shares Additional Paid-in Capital	Issued At Five Dollars And Twenty Cents Per Share To Tel Ventures In Exchange For Unidym S Shares	Issued At Five Dollars And Twenty Cents Per Share To Tel Ventures In Exchange For Unidym S Shares Common Stock	Issued At Five Dollars And Twenty Cents Per Share To Tel Ventures In Exchange For Unidym S Shares Additional Paid-in Capital	Arrowheads Increase In Proportionate Share Of Calandos Equity	Arrowheads Increase In Proportionate Share Of Calandos Equity Additional Paid-in Capital	Issued At Three Dollars Per Share	Issued At Three Dollars Per Share Common Stock	Issued At Three Dollars Per Share Additional Paid-in Capital	Issued To Unidym Stockholders In Exchange For Unidyms Shares Common Stock	Issued To Unidym Stockholders In Exchange For Unidyms Shares Additional Paid-in Capital	Issued To Unidym Stockholders In Exchange For Unidyms Shares Subscriptions Receivable	Issued To Unidym Stockholders In Exchange For Unidyms Shares Noncontrolling Interest	Issued at $6.34 per share	Issued at $6.34 per share Common Stock	Issued at $6.34 per share Additional Paid-in Capital	Issued at $13.12 per share	Issued at $13.12 per share Common Stock	Issued at $13.12 per share Additional Paid-in Capital	Issued To Calando Stockholders In Exchange For Calando S Shares	Issued To Calando Stockholders In Exchange For Calando S Shares Common Stock	Issued To Calando Stockholders In Exchange For Calando S Shares Additional Paid-in Capital	Issued To Calando Stockholders In Exchange For Calando S Shares Noncontrolling Interest	Issued at $3.80 per share	Issued at $3.80 per share Common Stock	Issued at $3.80 per share Additional Paid-in Capital	Issued at $3.80 per share Subscriptions Receivable	Issuance Of Common Stock For Subscription Additional Paid-in Capital	Issuance Of Common Stock For Subscription Subscriptions Receivable	Issued at $3.70 per share	Issued at $3.70 per share Common Stock	Issued at $3.70 per share Additional Paid-in Capital	Issued at $4.00 per share	Issued at $4.00 per share Common Stock	Issued at $4.00 per share Additional Paid-in Capital	Issued at $6.23 per share	Issued at $6.23 per share Common Stock	Issued at $6.23 per share Additional Paid-in Capital	Issued at $5.11 per share	Issued at $5.11 per share Common Stock	Issued at $5.11 per share Additional Paid-in Capital	Issued at $2.76 per share	Issued at $2.76 per share Common Stock	Issued at $2.76 per share Additional Paid-in Capital	Issued at $2.76 per share Subscriptions Receivable	Issued Under Committed Capital Agreement Common Stock	Issued Under Committed Capital Agreement Additional Paid-in Capital	Preferred Stock Issued At Thousand Dollars Per Share	Preferred Stock Issued At Thousand Dollars Per Share Preferred Stock	Preferred Stock Issued At Thousand Dollars Per Share Additional Paid-in Capital	Issued at $4.49 per share	Issued at $4.49 per share Common Stock	Issued at $4.49 per share Additional Paid-in Capital	Issued at $2.26 per share	Issued at $2.26 per share Common Stock	Issued at $2.26 per share Additional Paid-in Capital	Issued at $2.12 per share	Issued at $2.12 per share Common Stock	Issued at $2.12 per share Additional Paid-in Capital	Issued at $1.83 per share	Issued at $1.83 per share Common Stock	Issued at $1.83 per share Additional Paid-in Capital	Issued At Five Dollar And Eighty Six Cents Per Share	Issued At Five Dollar And Eighty Six Cents Per Share Common Stock	Issued At Five Dollar And Eighty Six Cents Per Share Additional Paid-in Capital
Beginning Balance Amount at Sep. 30, 2002
Issuance and sold of Common Stock									300,000		168,000
Stock issuances								3,000	3,000	1,680,000	1,680	1,678,320
Stock issuance cost charged to additional paid-in capital													(168,000)	(168,000)
Net loss	(95,238)					(95,238)
Ending Balance Amount at Sep. 30, 2003	1,419,762	4,680		1,510,320		(95,238)
Ending Balance Shares at Sep. 30, 2003		468,000
Issuance and sold of Common Stock											47,500					50,000			660,879			70,553			15,000			35,623
Stock issuances										475,000	475	474,525	(96,500)	(96,500)	500,000	500	499,500	9,913,182	6,609	9,906,573	(150,469)	706	(151,175)	162,750	163	162,587	534,344	356	533,988
Stock issuance cost charged to additional paid-in capital	(991,318)			(991,318)
Net loss	(751,255)					(2,528,954)	1,777,699
Stock options exercised		7,500																													7,500			600
Stock options exercised, Amount	15,000	75		14,925																										15,000	75	14,925	6,000	6	5,994
Stock-based compensation	175,653			175,653
Ending Balance Amount at Sep. 30, 2004	11,227,149	13,645		12,059,997		(2,624,192)	1,777,699
Ending Balance Shares at Sep. 30, 2004		1,363,155
Issuance and sold of Common Stock		1,250																																						50,226
Stock issuances	50,000	12		49,988																																			2,000,000	502	1,999,498
Net loss	(6,733,427)					(6,854,918)	121,491
Stock options exercised																																		2,500			1,381,289
Stock options exercised, Amount																																	25,000	25	24,975	20,719,335	13,813	20,705,522
Stock-based compensation	508,513			508,513
Adjustments to additional paid in capital, reallocation of noncontrolling interest	230,087			230,087
Ending Balance Amount at Sep. 30, 2005	28,026,657	27,997		35,578,580		(9,479,110)	1,899,190
Ending Balance Shares at Sep. 30, 2005		2,798,419
Issuance and sold of Common Stock																																											20,485			1,500			559,000			2,536			20,838
Stock issuances																																										1,000,000	205	999,795	57,600	15	57,585	19,545,000	5,590	19,539,410	150,000	25	149,975	1,077,333	208	1,077,125
Net loss	(19,961,961)					(18,997,209)	(964,752)
Stock options exercised		11,579
Stock options exercised, Amount	341,537	116		341,421
Stock-based compensation	1,369,478			1,369,478
Ending Balance Amount at Sep. 30, 2006	31,605,644	34,156		59,113,369		(28,476,319)	934,438
Ending Balance Shares at Sep. 30, 2006		3,414,359
Issuance and sold of Common Stock																																																										284,945			143,122
Stock issuances																																																									15,152,215	2,849	15,149,366	5,400,000	1,431	5,398,569
Net loss	(30,712,947)					(29,931,118)	(781,829)
Stock options exercised		18,616
Stock options exercised, Amount	434,727	186		434,541
Stock-based compensation	2,175,544			2,175,544
Adjustments to additional paid in capital, reallocation of noncontrolling interest	2,401,394			2,401,394
Ending Balance Amount at Sep. 30, 2007	26,456,577	38,622		84,672,783		(58,407,437)	152,609
Ending Balance Shares at Sep. 30, 2007		3,861,042
Issuance and sold of Common Stock																																																																386,399			5,000			7,055			10,505			11,416			1,500
Stock issuances																																																															6,960,585	3,867	6,956,718	136,000	50	135,950	200,000	71	199,929	310,000	105	309,895	250,000	114	249,886	32,700	15	32,685
Net loss	(27,241,639)					(27,089,030)	(152,609)
Stock options exercised		10,536
Stock options exercised, Amount	290,027	106		289,921
Stock-based compensation	3,187,397			3,187,397
Adjustments to additional paid in capital, reallocation of noncontrolling interest	1,720,962			1,720,962
Ending Balance Amount at Sep. 30, 2008	12,302,609	42,950		97,756,126		(85,496,467)
Ending Balance Shares at Sep. 30, 2008		4,293,452
Issuance and sold of Common Stock																																																																																		205,839			222,222					919,664
Stock issuances																																																																																	1,133,676	2,059	1,131,617	1,158,333	2,222	1,156,111			2,758,993	9,197	2,749,796
Net loss	(19,308,392)					(19,308,392)
Stock-based compensation	2,676,170			2,676,170
Adjustments to additional paid in capital, reallocation of noncontrolling interest	16,297			16,297																																																																																			2,120,250	2,120,250
Reclassification of former Unidym mezzanine debt to equity	2,000,000			2,000,000
Issuance of preferred stock in subsidiary																																																																																													300,000	(300,000)
Amortization of discount on Unidym Series D Preferred Stock				163,960		(163,960)
Ending Balance Amount at Sep. 30, 2009	4,857,936	56,428		110,070,327	(300,000.00)	(104,968,819)
Ending Balance Shares at Sep. 30, 2009		5,641,177
Issuance and sold of Common Stock		225,189																																																																																										15,318					508,343			659,299			122,000
Stock issuances	1,066,050	2,250		1,063,600			200																																																																																					153	(1,435)		1,282	3,222,896	5,083	3,217,813	7,868,578	6,593	7,861,985		1,220	(160,667)	159,447
Net loss	(6,957,038)					(5,774,048)	(1,182,990)
Stock options exercised		688
Stock options exercised, Amount	7,631	7		7,624
Stock-based compensation	1,582,149			1,582,149
Issuance of preferred stock in subsidiary	300,000				300,000
Divestiture of Unidym	300,000			245,345			54,655
Establish derivative liability	(4,169,907)			(4,169,907)
Ending Balance Amount at Sep. 30, 2010	8,078,295	71,734		119,716,834		(110,742,867)	(967,406)
Ending Balance Shares at Sep. 30, 2010		7,172,014
Issuance and sold of Common Stock		8,656																																																																																																									1,458,917
Stock issuances	43,279	87		43,192																																																																																																						4,643,684	14,574	4,629,110		900,000	(900,000)
Net loss	(3,492,399)					(3,128,885)	(363,514)
Stock options exercised		2,700
Stock options exercised, Amount	13,884	27		13,857
Stock-based compensation	1,404,640			1,404,640
Adjustments to additional paid in capital, reallocation of noncontrolling interest				(849,707)			849,707
Issuance of preferred stock in subsidiary	1,618,509			1,618,509
Divestiture of Unidym	254,275						254,275
Ending Balance Amount at Sep. 30, 2011	12,564,167	86,422		127,476,436	(900,000.00)	(113,871,752)	(226,938)
Ending Balance Shares at Sep. 30, 2011		8,642,286
Issuance and sold of Common Stock		15,511																				1,217,159																																																																																					138,158						675,000			100,000			83,211			97,831			2,260,869			68,926			1,015
Stock issuances	50,406	16		50,390																	6,147,830	9,332	6,138,498																																																																																			425,000	1,382	523,618	(100,000)			2,247,750	6,750	2,241,000	400,000	1,000	399,000	500,001	83	499,918	500,001	98	499,903	5,796,240	2,261	5,809,979	(16,000)	689	(689)	1,015,000	1	1,014,999
Net loss	(22,110,723)					(21,125,928)	(984,795)
Stock options exercised	4,883	4,583
Stock options exercised, Amount	23,833	45		23,788																																																																																																		8,000			8,000
Stock-based compensation	1,241,404			1,241,404
Fractional shares redeemed in reverse stock split		(131)
Preferred stock converted to common stock, shares		275,782	(1,015)
Preferred stock converted to common stock		276	(1)	(275)
Ending Balance Amount at Sep. 30, 2012	8,808,909	108,354		145,917,968	(1,016,000.00)	(134,997,680)	(1,203,733)
Ending Balance Shares at Sep. 30, 2012		13,579,185
Issuance and sold of Common Stock		1,182,451																																																																																																																																	9,900			239,894			1,825,079			1,667,051			14,262,553
Stock issuances	2,054,599	1,183		2,053,416																																																																																																																														9,900,000	10	9,899,990	986,049	240	985,809	3,816,468	1,825	3,814,643	3,256,859	1,667	3,255,192	25,459,499	14,263	25,445,236
Net loss	(31,703,433)					(31,143,289)	(560,144)
Stock options exercised	675	675
Stock options exercised, Amount	2,579	1		2,578
Stock-based compensation	1,536,271			1,536,271
Subscription payment	16,000				16,000
Subscription reversal, Shares		(267,444)
Subscription reversal		(2,674)		(997,326)	1,000,000
Establish and settlements related to derivative liability	1,600,989			1,600,989
Ending Balance Amount at Sep. 30, 2013	25,734,789	124,859	10	193,514,766		(166,140,969)	(1,763,877)
Ending Balance Shares at Sep. 30, 2013		32,489,444	9,900
Issuance and sold of Common Stock		848,961																																																																																																																																	46,000															3,071,672
Stock issuances	2,434,563	849		2,433,714																																																																																																																														46,000,000	46	45,999,954													14,060,112	3,072	14,057,040
Net loss	(10,685,732)					(10,628,312)	(57,420)
Stock options exercised	62,825	73,496
Stock options exercised, Amount	326,917	73		326,844
Stock-based compensation	521,138			521,138
Preferred stock converted to common stock, shares		2,518,579	(4,609)
Preferred stock converted to common stock		2,519	(5)	(2,514)
Establish and settlements related to derivative liability	2,518,500			2,518,500
Ending Balance Amount at Dec. 31, 2013	$ 80,910,287	$ 131,372	$ 51	$ 259,369,442		$ (176,769,281)	$ (1,821,297)
Ending Balance Shares at Dec. 31, 2013		39,002,152	51,291